In Vivo Cell Tracking with Bioluminescence Imaging

被引：106
作者：
Kim J.E. [1 ]
Kalimuthu S. [1 ]
Ahn B.-C. [1 ]
机构：
[1] Department of Nuclear Medicine, Kyungpook National University School of Medicine and Hospital, 50, Samduk 2-ga, Jung Gu, Daegu
来源：
Nuclear Medicine and Molecular Imaging | 2015年 / 49卷 / 1期
基金：
新加坡国家研究基金会;
关键词：
Bioluminescence; Cell therapy; Cell tracking; In vivo imaging; Optical imaging;
D O I：
10.1007/s13139-014-0309-x
中图分类号：
学科分类号：
摘要：
Molecular imaging is a fast growing biomedical research that allows the visual representation, characterization and quantification of biological processes at the cellular and subcellular levels within intact living organisms. In vivo tracking of cells is an indispensable technology for development and optimization of cell therapy for replacement or renewal of damaged or diseased tissue using transplanted cells, often autologous cells. With outstanding advantages of bioluminescence imaging, the imaging approach is most commonly applied for in vivo monitoring of transplanted stem cells or immune cells in order to assess viability of administered cells with therapeutic efficacy in preclinical small animal models. In this review, a general overview of bioluminescence is provided and recent updates of in vivo cell tracking using the bioluminescence signal are discussed. © 2014, Korean Society of Nuclear Medicine.
引用
收藏
页码：3 / 10
页数：7
相关论文
共 85 条
  • [1] Cao F., Lin S., Xie X., Ray P., Patel M., Zhang X., Et al., In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery, Circulation, 113, 7, pp. 1005-1014, (2006)
  • [2] Zeiser R., Nguyen V.H., Beilhack A., Buess M., Schulz S., Baker J., Et al., Inhibition of CD4+ CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production, Blood, 108, 1, pp. 390-399, (2006)
  • [3] Berman S.C., Galpoththawela C., Gilad A.A., Bulte J.W., Walczak P., Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells, Magn Reson Med, 65, 2, pp. 564-574, (2011)
  • [4] Acton P., Zhou R., Imaging reporter genes for cell tracking with PET and SPECT, Q J Nucl Med Mol Imaging, 49, 4, pp. 349-360, (2005)
  • [5] Zhang Y., Ruel M., Beanlands R.S., Dekemp R.A., Suuronen E.J., DaSilva J.N., Tracking stem cell therapy in the myocardium: applications of positron emission tomography, Curr Pharm Design, 14, 36, pp. 3835-3853, (2008)
  • [6] Ahn B.C., Applications of molecular imaging in drug discovery and development process, Curr Pharm Biotechnol, 12, 4, pp. 459-468, (2011)
  • [7] Chao F., Shen Y., Zhang H., Tian M., Multimodality molecular imaging of stem cells therapy for stroke, BioMed Res Int, (2013)
  • [8] Yang C.Y., Hsiao J.K., Tai M.-F., Chen S.T., Cheng H.Y., Wang J.L., Et al., Direct labeling of hMSC with SPIO: the long-term influence on toxicity, chondrogenic differentiation capacity, and intracellular distribution, Mol Imag Biol, 13, 3, pp. 443-451, (2011)
  • [9] Kraitchman D.L., Bulte J.W., In vivo imaging of stem cells and beta cells using direct cell labeling and reporter gene methods, Arterioscler Thromb Vasc Biol, 29, 7, pp. 1025-1030, (2009)
  • [10] Keyaerts M., Caveliers V., Lahoutte T., Bioluminescence imaging: looking beyond the light, Trends Mol Med, 18, 3, pp. 164-172, (2012)
123456789